Concepedia

Publication | Closed Access

The 5-Year Outcome of ABO-Incompatible Kidney Transplantation With Rituximab Induction

127

Citations

14

References

2011

Year

Abstract

In the long term, inclusion of rituximab in the preoperative regimen yielded an even better outcome than that of ABO-CKT and rituximab-untreated ABO-IKT, without any increase in the risk of infection.

References

YearCitations

Page 1